Pharmafile.com’s top 10 news stories of the week
February 5, 2021Medical Communications COVID-19
In the last week, a number of COVID-19 vaccine developments have been made. Johnson & Johnson’s one-shot jab was found …
New Oxford University-AstraZeneca vaccine against COVID-19 mutations could be available by October
February 5, 2021Medical Communications AstraZeneca, COVID-19
Oxford University and AstraZeneca could release a new vaccine by October in order to counter the new mutations of COVID-19 …
Pfizer withdraws application for emergency vaccine authorisation in India
February 5, 2021Medical Communications COVID-19, Pfizer
Pfizer has withdrawn its application in India for emergency use authorisation of its vaccine, which it has produced with German …
Hyloris and Purna Female Healthcare partner to develop novel women’s health product
February 5, 2021Medical Communications Hyloris, women
Hyloris Pharmaceuticals and Purna Female Healthcare (PFH), a spin-off founded by Purna Pharmaceuticals and Creafund, have entered into a partnership …
AstraZeneca’s Imfinzi misses target in Phase III head and neck cancer trial
February 5, 2021Medical Communications AstraZeneca, Cancer
AstraZeneca’s Imfinzi (durvalumab) has failed to improve overall survival (OS) for patients with recurrent or metastatic head and neck cancer …
Destiny Pharma appoints Professor Mark Wilcox to its Scientific Advisory Board
February 4, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Destiny Pharma, a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening …
Scripps Research and IAVI report positive findings from HIV vaccine Phase I trial
February 4, 2021HIV
Scripps Research and IAVI have returned positive Phase I results in their hunt for a HIV vaccine, detecting a targeted …
China approves AstraZeneca’s heart failure drug Forxiga
February 4, 2021AstraZeneca, Forxiga
AstraZeneca’s Forxiga (dapagliflozin) has been approved for use in China to reduce the risk of death and hospitalisation from heart …
Raremark appoints Caroline O’Connor as CCO
February 4, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Raremark has appointed Caroline O’Connor as its new Chief Commercial Officer. Previously holding the position of Raremark’s Senior Vice President …
Pfizer and Imcyse enter research and licence agreement for rheumatoid arthritis programme
February 4, 2021Imcyse, Pfizer
Imcyse has entered into a research collaboration and licence agreement with Pfizer for Imcyse’s rheumatoid arthritis (RA) programme based on …
NICE recommends MSD’s Keytruda in combination with chemotherapy for lung cancer
February 4, 2021Cancer, MSD
NICE has recommended MSD’s Keytruda (pembrolizumab) with pemetrexed and platinum chemotherapy (pembrolizumab combination) as a first-line option for untreated, metastatic, …
Jazz acquires GW Pharmaceuticals in $7.2 billion deal
February 4, 2021cannabinoid, jazz pharmaceuticals
Jazz Pharmaceuticals has acquired GW Pharmaceuticals for over $7 billion, with the transition expected to close in the second quarter …
Pharmafile.com’s weekly COVID-19 news round-up
February 3, 2021Research and Development COVID-19
The past week has seen mostly positive COVID-19 vaccine developments; Pfizer has confirmed its jab is effective against both the …
Longer Oxford-AstraZeneca vaccine interval improves efficacy, report says
February 3, 2021Research and Development AstraZeneca, COVID-19
A longer interval between doses of the Oxford University-AstraZeneca vaccine could substantially improve efficacy, according to a report published in …
GSK and CureVac sign £132m deal to develop next-generation COVID-19 vaccine
February 3, 2021Research and Development COVID-19, CureVac, GlaxoSmithKline
GlaxoSmithKline (GSK) and CureVac have today announced they are joining forces to develop a new COVID-19 vaccine to combat future …
CHMP recommends marketing authorisation for Incyte’s pemigatinib
February 3, 2021Research and Development EMA, Incyte
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the conditional marketing authorisation of Incyte’s pemigatinib for …
New urine test could detect womb cancer in three hours
February 3, 2021Research and Development Cancer, urine test
A simple test using patented technology to detect the cancer biomarker MCM5 (Minichromosome Maintenance Complex Component 5) in urine could …
Scenic Biotech appoints Dr Philippe Dro as Chairman
February 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Scenic Biotech has announced the appointment of Dr Philippe Dro as its independent Chairman. Dr Dro replaces Dr Ulrich Grau, …
Chelsea & Westminster Hospital launches diabetes care app
February 2, 2021Manufacturing and Production
Chelsea and Westminster Hospital NHS Foundation Trust have today announced the use of a new app designed to revolutionise diabetes …
FDA approves new IM administration route for Biogen’s MS drug Plegridy
February 2, 2021Manufacturing and Production Biogen, MS
The FDA has approved a new intramuscular (IM) injection route of administration for Biogen’s Plegridy (peginterferon beta-1a) for the treatment …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
